Literature DB >> 22118180

Study of KIR genes in Lebanese patients with tuberculosis.

R Mahfouz1, H Halas, R Hoteit, M Saadeh, W Shamseddeen, K Charafeddine, L Itani, G F Araj.   

Abstract

A total of 103 Lebanese tuberculosis (TB) cases and 38 controls without TB were studied for the killer cell immunoglobulin-like receptors (KIR) genotypic profile using polymerase chain reaction sequence-specific primers. Patients and controls were assigned to the AA, AB or BB genotypes based on their A or B haplotype genetic make-up, and KIR gene frequencies were compared. We found an increase in the KIR A haplotype in TB patients compared to controls, and only KIR 2DL3 was found to be significantly more prevalent among TB patients. This confirms the findings of another unique international study performed in the Mexican population showing a greater repertoire of inhibitory KIR genes among TB patients than controls.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22118180     DOI: 10.5588/ijtld.11.0138

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  13 in total

1.  Systematic review and meta-analytic findings on the association between killer-cell immunoglobulin-like receptor genes and susceptibility to pulmonary tuberculosis.

Authors:  Melodi Omraninava; Sahar Mehranfar; Arezou Khosrojerdi; Sirous Jamalzehi; Jafar Karami; Morteza Motallebnezhad; Mohammad Reza Javan; Saeed Aslani; Hamed Mohammadi; Ahmad Kousha
Journal:  Pathog Glob Health       Date:  2020-12-01       Impact factor: 2.894

2.  Natural killer cells are recruited during pulmonary tuberculosis and their ex vivo responses to mycobacteria vary between healthy human donors in association with KIR haplotype.

Authors:  Damien Portevin; Laura E Via; Seokyong Eum; Douglas Young
Journal:  Cell Microbiol       Date:  2012-07-30       Impact factor: 3.715

3.  Evaluation of host genetics on outcome of tuberculosis infection due to differences in killer immunoglobulin-like receptor gene frequencies and haplotypes.

Authors:  Kali Braun; Joyce Wolfe; Sandra Kiazyk; Meenu Kaushal Sharma
Journal:  BMC Genet       Date:  2015-06-16       Impact factor: 2.797

4.  KIR genotype distribution among Lebanese patients with Hodgkin's lymphoma.

Authors:  Rouba Hoteit; Miguel Abboud; Ali Bazarbachi; Ziad Salem; Dina Shammaa; Ghazi Zaatari; Rami Mahfouz
Journal:  Meta Gene       Date:  2015-03-25

Review 5.  Molecular studies on ancient M. tuberculosis and M. leprae: methods of pathogen and host DNA analysis.

Authors:  H W Witas; H D Donoghue; D Kubiak; M Lewandowska; J J Gładykowska-Rzeczycka
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-26       Impact factor: 3.267

6.  Killer immunoglobulin-like receptor (KIR) centromeric-AA haplotype is associated with ethnicity and tuberculosis disease in a Canadian First Nations cohort.

Authors:  Kali Braun; Linda Larcombe; Pamela Orr; Peter Nickerson; Joyce Wolfe; Meenu Sharma
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

7.  Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.

Authors:  Chrissy H Roberts; Sandra Molina; Pateh Makalo; Hassan Joof; Emma M Harding-Esch; Sarah E Burr; David C W Mabey; Robin L Bailey; Matthew J Burton; Martin J Holland
Journal:  PLoS Negl Trop Dis       Date:  2014-03-20

8.  Reproduction, infection and killer-cell immunoglobulin-like receptor haplotype evolution.

Authors:  Bridget S Penman; Ashley Moffett; Olympe Chazara; Sunetra Gupta; Peter Parham
Journal:  Immunogenetics       Date:  2016-08-12       Impact factor: 2.846

Review 9.  Memory of Natural Killer Cells: A New Chance against Mycobacterium tuberculosis?

Authors:  José Alberto Choreño Parra; Nayeli Martínez Zúñiga; Luis Antonio Jiménez Zamudio; Luis Armando Jiménez Álvarez; Citlaltepetl Salinas Lara; Joaquín Zúñiga
Journal:  Front Immunol       Date:  2017-08-14       Impact factor: 7.561

Review 10.  Influence of Genetic Polymorphism Towards Pulmonary Tuberculosis Susceptibility.

Authors:  Murugesan Harishankar; Paramasivam Selvaraj; Ramalingam Bethunaickan
Journal:  Front Med (Lausanne)       Date:  2018-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.